Jun Okada
Präsident bei 3-D MATRIX, LTD.
Vermögen: 177 545 $ am 30.06.2024
Profil
Jun Okada is currently the President & Representative Director at 3-D Matrix Ltd.
He is also a Director at 3-D Matrix, Inc., 3-D Matrix Da America Latina Representacão Comercial Ltda., 3-D Matrix Asia Pte.
Ltd., 3-D Matrix Europe SAS, and Beijing 3-D Matrix Investment Consulting, Ltd.
Mr. Okada has an MBA from INSEAD and a graduate degree from the University of Tokyo Faculty of Law & Graduate Schools for Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
3-D MATRIX, LTD.
0,25% | 30.04.2023 | 204 000 ( 0,25% ) | 177 545 $ | 30.06.2024 |
Aktive Positionen von Jun Okada
| Unternehmen | Position | Beginn |
|---|---|---|
| 3-D MATRIX, LTD. | Präsident | 01.03.2016 |
| 3-D Matrix Asia Pte. Ltd. | Direktor/Vorstandsmitglied | 01.10.2012 |
3-D Matrix Da America Latina Representacão Comercial Ltda.
 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Direktor/Vorstandsmitglied | 01.06.2014 |
| Beijing 3-D Matrix Investment Consulting, Ltd. | Direktor/Vorstandsmitglied | 01.08.2014 |
3-D Matrix Europe SAS
 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Direktor/Vorstandsmitglied | 01.04.2012 |
| 3-D Matrix, Inc. | Direktor/Vorstandsmitglied | 01.04.2016 |
Ausbildung von Jun Okada
| INSEAD | Masters Business Admin |
| University of Tokyo Faculty of Law & Graduate Schools for Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 3-D MATRIX, LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| 3-D Matrix Asia Pte. Ltd. | |
3-D Matrix Da America Latina Representacão Comercial Ltda.
3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Health Technology |
| Beijing 3-D Matrix Investment Consulting, Ltd. | |
3-D Matrix Europe SAS
3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Health Technology |
| 3-D Matrix, Inc. |
